Form 8.3 SPIRE HEALTHCARE GROUP PLC

Summary by AI BETAClose X

Barclays PLC disclosed on 2 November 2026 that as at 30 October 2026 it holds 6,284,535 Spire Healthcare ordinary shares (1.56%) and short positions of 6,374,138 shares (1.58%), with cash-settled derivatives representing 6,379,073 shares long (1.58%) and 6,318,069 shares short (1.57%); aggregate economic exposure is 12,663,608 shares (3.14%) long and 12,692,207 shares (3.15%) short. Barclays executed net purchases of 37,341 ordinary shares at approximately £2.49 per share and disclosed no stock-settled derivatives or indemnity/arrangement inducements.

Disclaimer*

UK 100

Latest directors dealings